GlassScriptPhysician profile
Marchele L Johnson
NPI 1831537497
$2,797.17
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $56.14 · 2022: $2,227 · 2023: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $514.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $1,430.18 | 2022 | |
| Collegium Pharmaceutical, INC. | $296.01 | 2022-2023 | Xtampza |
| Abbvie INC. | $233.32 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $171.57 | 2022-2023 | Relistor |
| Scilex Pharmaceuticals INC. | $117.34 | 2022-2023 | Ztlido |
| Teva Pharmaceuticals USA, INC. | $111.98 | 2022-2023 | Ajovy |
| Grt US Holding, INC. | $109.73 | 2021-2022 | |
| Pfizer INC. | $52.66 | 2023 | |
| Valinor Pharma, LLC | $43.82 | 2023 | Movantik |
| Almatica Pharma LLC | $38.98 | 2021-2022 | |
| Azurity Pharmaceuticals, INC. | $38.26 | 2023 | Horizant |
| Nevro Corp. | $33.97 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $25.04 | 2021 | |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Horizon Therapeutics Plc | $20.85 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impel Pharmaceuticals INC. | $19.12 | 2022 | |
| Ibsa Pharma INC. | $17.59 | 2023 | Tirosint, Licart |
| Medtronic, INC. | $15.75 | 2023 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marchele Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.